Blueprint Medicines Corporation - Current Ratio

The Current Ratio as of June 2026 (TTM) for Blueprint Medicines Corporation (BPMC) is 2.80

According to Blueprint Medicines Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 2.80. This represents a change of -11.57% compared to the average of 3.17 of the last 4 quarters.

Blueprint Medicines Corporation (BPMC) Historical Current Ratio (quarterly & annually)

How has BPMC Current Ratio performed in the past?

The mean historical Current Ratio of Blueprint Medicines Corporation over the last ten years is 6.91. The current 2.80 Current Ratio has changed 3.95% with respect to the historical average. Over the past ten years (40 quarters), BPMC's Current Ratio was at its highest in in the December 2017 quarter at 15.98. The Current Ratio was at its lowest in in the March 2025 quarter at 2.80.

Blueprint Medicines Corporation (BPMC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Blueprint Medicines Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Blueprint Medicines Corporation (BPMC) Average Current Ratio

How has BPMC Current Ratio performed in the past?

The current Current Ratio of Blueprint Medicines Corporation (BPMC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Blueprint Medicines Corporation (BPMC) Current Ratio vs. Peers

How is BPMC’s Current Ratio compared to its peers?

Blueprint Medicines Corporation’s Current Ratio is less than Cerevel Therapeutics Holdings, Inc. (10.92), greater than ImmunoGen, Inc. (2.26), less than Roivant Sciences Ltd. (18.37), less than Prometheus Biosciences, Inc. (31.04), less than Reata Pharmaceuticals, Inc. (6.75), less than IVERIC bio, Inc. (18.63), greater than Signify Health, Inc. (1.62), greater than Oak Street Health, Inc. (1.41), less than RayzeBio, Inc. Common Stock (28.69), less than Karuna Therapeutics, Inc. (19.31),

Build a custom stock screener for Blueprint Medicines Corporation (BPMC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Blueprint Medicines Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Blueprint Medicines Corporation (BPMC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Blueprint Medicines Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.